Endocrinology

Chapter 8 Endocrinology






Basic concepts




2 What is the cellular mechanism of action of the peptide hormones and the catecholamines?


The peptide hormones and catecholamines are not highly lipid-diffusible and thus cannot cross the plasma membrane. They bind to cell surface receptors (see Fig. 8-1), which initiate a variety of biochemical events, including activation or inhibition of enzymes, alteration of membrane proteins, and mediation of cellular trafficking. These processes can occur within seconds to minutes. Nevertheless, the peptide hormones can stimulate gene expression as well, and this effect is delayed as it is with the steroid hormones. Examples of peptide hormones are insulin, parathyroid hormone (PTH), vasopressin (antidiuretic hormone), and oxytocin. Table 8-1 shows a comparison of polypeptide and steroid hormones.






5 What are the four primary classes of membrane-spanning receptors to which peptide hormones bind?


The four primary classes of membrane-spanning receptors to which peptide hormones bind are (1) tyrosine and serine kinase receptors, (2) receptor-linked kinases, (3) G protein–coupled receptors, and (4) ligand-gated ion channels (Fig. 8-2 and Table 8-2). As a gross simplification, the “prototypical” agonists for these receptor types can be considered to be growth factors, growth hormones (GHs), peptide hormones, and neurotransmitters, respectively.



Table 8-2 Classes of Receptors Used by Various Hormones





















Receptor Class Hormones and Related Substances
cAMP LH, FSH, ACTH, TSH, PTH, hCG, CRH, glucagon
cGMP NO, ANP
IP3 GnRH, GHRH, oxytocin, TRH
Steroid receptor Estrogen, testosterone, glucocorticoids, vitamin D, aldosterone, progesterone, T3/T4
Tyrosine kinase Insulin, growth factors (e.g., IGF, PDGF), GH, prolactin

ACTH, adrenocorticotropic hormone; ANP, atrial natriuretic peptide; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; CRH, corticotropin-releasing hormone; FSH, follicle-stimulating hormone; GH, growth hormone; GHRH, growth hormone–releasing hormone; GnRH, gonadotropin-releasing hormone; hCG, human chorionic gonadotropin; IGF, insulin-like growth factor; IP3, inositol triphosphate; NO, nitric oxide; PDGF, platelet-derived growth factor; PTH, parathyroid hormone; T3, triiodothyronine; T4, thyroxine; TRH, thyrotropin-releasing hormone; TSH, thyroid-stimulating hormone.




6 How do the tyrosine kinase receptors transduce their messages?


As depicted in Figure 8-3, binding of peptide hormone to the extracellular domain of the receptor initiates a signal transduction cascade by promoting autophosphorylation of the kinase receptor and subsequent phosphorylation of downstream target proteins, thereby activating or inhibiting these proteins.





8 How do the G proteins transduce their signals?


Binding of hormone/agonist to G protein–coupled receptors causes an αβγ subunit complex to exchange guanosine diphosphate (GDP) for guanosine triphosphate (GTP). Once GTP is bound to the subunit complex, it dissociates into the α subunit and a separate βγ subunit. These dissociated subunits then activate or inhibit enzymes (adenylate cyclase, phospholipase) and ion channels (Ca2+ channels) (Fig. 8-4).



Note: Adenylate cyclase synthesizes cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP), and the cAMP activates various target proteins. Gs receptors stimulate adenylate cyclase, whereas Gi receptors inhibit adenylate cyclase.



Step 1 Secret


G proteins are a five-star topic on boards. Study the pathways for Gs, Gi, and Gq signaling depicted in Figure 8-4. You should know the details of these pathways, including the predominant cellular changes that occur with activation of each protein (e.g., cyclic adenosine monophosphate [cAMP] increase with Gs activation, intracellular [Ca2+] increase with Gq activation).




10 Describe the concept of negative feedback. What is a feedback loop?


Hormone synthesis and release are governed at multiple levels. Hormone synthesis/release from an organ of interest typically involves regulation by a pituitary hormone, which itself is regulated by a hypothalamic hormone. This general pathway structure is commonly referred to as a hypothalamic-pituitary-(organ) axis (e.g., HPO axis refers to the ovary, HPA axis refers to the adrenal gland). Negative feedback occurs when a product downstream of an axis inhibits production of a reactant by which it is regulated; for example, thyroid hormone inhibition of thyroid-stimulating hormone (TSH). These relationships are often depicted using feedback loops. An example of the thyroid hormone feedback loop is depicted in Figure 8-6.










6 Why wouldn’t hypothalamic dopamine secretion be elevated from an anterior pituitary infarction?


In contrast with the other hypothalamic hormones, dopamine is inhibitory in nature and reduces the secretion of prolactin by the lactotrophs. Because serum prolactin normally stimulates dopamine secretion from the hypothalamus, in a setting of hypoprolactinemia secondary to pituitary infarction, we would expect decreased secretion of hypothalamic dopamine.













9 Why does hypothyroidism need to be considered in the evaluation of hyperprolactinemia?


Hypothalamic thyrotropin-releasing hormone (TRH) stimulates the secretion of both TSH and prolactin by the anterior pituitary. Because hypothyroidism causes elevated levels of TRH, it should be ruled out as a potential cause of hyperprolactinemia.











7 What growth abnormality results from deficient secretion of growth hormone during the growing years?


Pituitary dwarfism is the most common result of this deficiency.


Note: The dwarfism caused by deficient GH secretion is proportional (i.e., the limbs and trunk are of normal relative proportions), as opposed to the comparatively shorter limbs characteristic of dwarfism caused by achondroplasia. Of note, achondroplasia is caused by mutations of the fibroblast growth factor receptor gene 3 (FGFR3), which inhibit bone growth.
















12 One treatment for Cushing disease is to remove both adrenal glands (bilateral adrenalectomy). What might happen to the pituitary gland following such a surgery?


The removal of both adrenal glands will stop the production of cortisol. Lacking the negative feedback of cortisol, the pituitary will synthesize ACTH and melanocyte-stimulating hormone (MSH) unchecked, leading to enlargement of the preexisting pituitary adenoma with resulting headache and diffuse hyperpigmentation. This is known as Nelson’s syndrome.


Note: MSH production is elevated when ACTH production is increased because both are produced from the same precursor polypeptide (pro-opiomelanocortin [POMC]).






Stay updated, free articles. Join our Telegram channel

Apr 7, 2017 | Posted by in NURSING | Comments Off on Endocrinology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access